124 related articles for article (PubMed ID: 8763266)
1. Malignant meningitis: a rational approach to cerebrospinal fluid cytology.
MacKenzie JM
J Clin Pathol; 1996 Jun; 49(6):497-9. PubMed ID: 8763266
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
Groves MD; Hess KR; Puduvalli VK; Colman H; Conrad CA; Gilbert MR; Weinberg J; Cristofanilli M; Yung WK; Liu TJ
J Neurooncol; 2009 Sep; 94(2):229-34. PubMed ID: 19267183
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis.
Müller HL; Oh Y; Gargosky SE; Lehrnbecher T; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Nov; 77(5):1113-9. PubMed ID: 7521338
[TBL] [Abstract][Full Text] [Related]
5. Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitis.
Shingyoji M; Kageyama H; Sakaida T; Nakajima T; Matsui Y; Itakura M; Iuchi T; Yokoi S; Kimura H; Iizasa T
J Thorac Oncol; 2011 Jul; 6(7):1215-20. PubMed ID: 21610522
[TBL] [Abstract][Full Text] [Related]
6. Neoplastic meningitis: How MRI and CSF cytology are influenced by CSF cell count and tumor type.
Prömmel P; Pilgram-Pastor S; Sitter H; Buhk JH; Strik H
ScientificWorldJournal; 2013; 2013():248072. PubMed ID: 24453817
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas.
Fischer L; Jahnke K; Martus P; Weller M; Thiel E; Korfel A
Haematologica; 2006 Mar; 91(3):429-30. PubMed ID: 16531273
[TBL] [Abstract][Full Text] [Related]
8. Cytopathology of nonlymphoreticular neoplasms metastatic to the central nervous system.
Ehya H; Hajdu SI; Melamed MR
Acta Cytol; 1981; 25(6):599-610. PubMed ID: 6947665
[TBL] [Abstract][Full Text] [Related]
9. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers.
Chamberlain MC
Neurology; 1998 Apr; 50(4):1173-5. PubMed ID: 9566421
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid cytology diagnosis of meningeal carcinomatosis in patients with small-cell carcinoma of the lung. A study of interobserver and intraobserver variability.
Pedersen AG; Olsen J; Nasiell M
Acta Cytol; 1986; 30(6):648-52. PubMed ID: 3024430
[TBL] [Abstract][Full Text] [Related]
11. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis.
Rhodes CH; Glantz MJ; Glantz L; Lekos A; Sorenson GD; Honsinger C; Levy NB
Cancer; 1996 Feb; 77(3):543-8. PubMed ID: 8630963
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
Hovestadt A; Henzen-Logmans SC; Vecht CJ
Br J Cancer; 1990 Oct; 62(4):653-4. PubMed ID: 2223585
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia.
Almeida SM; Nanakanishi E; Conto AJ; Souza LP; Antonelli Filho D; Roda CD
Arq Neuropsiquiatr; 2007 Sep; 65(3B):802-9. PubMed ID: 17952285
[TBL] [Abstract][Full Text] [Related]
14. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology.
Glass JP; Melamed M; Chernik NL; Posner JB
Neurology; 1979 Oct; 29(10):1369-75. PubMed ID: 573381
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic meningitis: a retrospective review of clinical presentations, radiological and cerebrospinal fluid findings.
Jearanaisilp S; Sangruji T; Danchaivijitr C; Danchaivijitr N
J Med Assoc Thai; 2014 Aug; 97(8):870-7. PubMed ID: 25345264
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancer.
Togashi Y; Masago K; Fukudo M; Terada T; Fujita S; Irisa K; Sakamori Y; Kim YH; Mio T; Inui K; Mishima M
J Thorac Oncol; 2010 Jul; 5(7):950-5. PubMed ID: 20479691
[TBL] [Abstract][Full Text] [Related]
17. Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades.
Wauters CA; Poelen J; Mulder I; Venderink D; Strobbe LJ; Wesseling P
J Neurooncol; 2012 May; 107(3):581-9. PubMed ID: 22215233
[TBL] [Abstract][Full Text] [Related]
18. Comparison between cytospin and liquid-based cytology in cerebrospinal fluid diagnosis of neoplastic diseases: A single institution experience.
Straccia P; Fadda G; Pierconti F
Cytopathology; 2019 Mar; 30(2):236-240. PubMed ID: 30468697
[TBL] [Abstract][Full Text] [Related]
19. Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia.
Lee W; Kim SJ; Lee S; Kim J; Kim M; Lim J; Kim Y; Cho B; Lee EJ; Han K
Ann Clin Lab Sci; 2005; 35(4):407-12. PubMed ID: 16254256
[TBL] [Abstract][Full Text] [Related]
20. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies.
Tawfik B; Brown L; Fuda F; Chen W; Niu S; Sailors J; Sadeghi N
Ann Hematol; 2018 Sep; 97(9):1707-1716. PubMed ID: 29680874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
